RxDoctor Payments Data

Krysten Jenkins, PA

Physician Assistant · Norman, OKNPI 1952723488

Payments from drug & device makers

$1,935in general payments, 2019–2025

Across 105 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$384
  • AbbVie$240
  • AstraZeneca$226
  • Astellas Pharma US Inc$181
  • Pfizer$156
  • Lilly USA, LLC$129
  • plus $619 from 11 others

What the payments were for

  • Food & beverage$1,87097%
  • Education$653%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,935 in reported general payments places this provider in the 80th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$18,061
Medicare patients
114
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide35$38,654
OzempicSemaglutide11$17,600
Albuterol Sulfate HfaAlbuterol Sulfate40$857
Omeprazole37$680
Estradiol21$576
Atorvastatin Calcium36$536
Levothyroxine Sodium50$524
Fluticasone Propionate14$421
Buspirone Hcl25$366
Celecoxib23$349
Montelukast Sodium16$345
Gabapentin37$341
Duloxetine Hcl15$297
Losartan Potassium25$294
Trazodone Hcl24$250

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$129$38,65435 claims
Novo NordiskOzempic$127$17,60011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Norman

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →